drugset
drugset / Trial / NCT06870370

Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI

NCT06870370 ↗

Phase 3 Not yet recruiting 60 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury

Timeline

Start
2025-09-20
Primary completion
2025-09-20
Completion
2025-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 1 mg Intravenous

Indications

intracranial hypertension traumatic brain injury